The sale is a routine tax-withholding transaction tied to equity vesting. No change in outlook; monitor future Form 4 filings for actual execution and any larger non-tax-motivated sales.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Emily M. Leproust filed a Form 144 notice of intent to sell 19,045 shares of Twist Bioscience common stock, valued at approximately $1.97 million, to cover a tax obligation from vested equity award settlement. The sale is routine and small relative to her prior trading activity and the company's market cap, carrying no material signal.
Key Facts
- Insider: CEO Emily M. Leproust
- Shares to be sold: 19,045 shares of common stock
- Approximate value: $1,974,745.58
- Sale date: November 16, 2026
- Reason: tax obligation from vested equity award distribution
- Prior sales by Leproust in 2026: multiple transactions totaling over 460,000 shares
Financial Impact
19,045 shares, ~$1.97M, representing a small fraction of CEO's total holdings and company market cap
Risk Factors
- CEO has been a consistent seller throughout 2026, which could indicate ongoing portfolio diversification or reduced conviction
- Form 144 is an intent to sell; actual sale may not occur
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-008059 |
| Document: 0001959173-26-008059-index.html | 0001959173-26-008059 |
| Document: 0001959173-26-008059.txt | 0001959173-26-008059 |
Track record
49 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $102.98 Now $105.04 +2.00% settles Dec 16
- Nov 16, 20261d ago 144 Neutral 2/10 Viewing Entry $104.30 Now $105.04 +0.71% settles Dec 16
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $105.04 Now $105.04 +0.00% settles Dec 15
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $105.04 Now $105.04 +0.00% settles Dec 15
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $105.04 Now $105.04 +0.00% settles Dec 15
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $105.04 Now $105.04 +0.00% settles Dec 15
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $105.04 Now $105.04 +0.00% settles Dec 15
- Nov 12, 20265d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20265d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20267d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers